These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 8239593)

  • 1. Antileishmanial activity of sodium stibogluconate fractions.
    Roberts WL; Rainey PM
    Antimicrob Agents Chemother; 1993 Sep; 37(9):1842-6. PubMed ID: 8239593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Axenically grown amastigotes of Leishmania infantum used as an in vitro model to investigate the pentavalent antimony mode of action.
    Sereno D; Cavaleyra M; Zemzoumi K; Maquaire S; Ouaissi A; Lemesre JL
    Antimicrob Agents Chemother; 1998 Dec; 42(12):3097-102. PubMed ID: 9835497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pentostam induces resistance to antimony and the preservative chlorocresol in Leishmania donovani promastigotes and axenically grown amastigotes.
    Ephros M; Waldman E; Zilberstein D
    Antimicrob Agents Chemother; 1997 May; 41(5):1064-8. PubMed ID: 9145870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro antileishmanial properties of tri- and pentavalent antimonial preparations.
    Roberts WL; Berman JD; Rainey PM
    Antimicrob Agents Chemother; 1995 Jun; 39(6):1234-9. PubMed ID: 7574507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical mechanisms of the antileishmanial activity of sodium stibogluconate.
    Berman JD; Waddell D; Hanson BD
    Antimicrob Agents Chemother; 1985 Jun; 27(6):916-20. PubMed ID: 2411217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decanethiol functionalized silver nanoparticles are new powerful leishmanicidals in vitro.
    Isaac-Márquez AP; Talamás-Rohana P; Galindo-Sevilla N; Gaitan-Puch SE; Díaz-Díaz NA; Hernández-Ballina GA; Lezama-Dávila CM
    World J Microbiol Biotechnol; 2018 Feb; 34(3):38. PubMed ID: 29460068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leishmania donovani: effect of verapamil on in vitro susceptibility of promastigote and amastigote stages of Indian clinical isolates to sodium stibogluconate.
    Valiathan R; Dubey ML; Mahajan RC; Malla N
    Exp Parasitol; 2006 Oct; 114(2):103-8. PubMed ID: 16616137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro efficacy of some drugs on promastigotes of Leishmania donovani.
    Al-Khateeb GH; Al-Jeboori TI; Al-Janabi KA
    Chemotherapy; 1977; 23(4):267-75. PubMed ID: 16732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro sensitivity testing of Leishmania clinical field isolates: preconditioning of promastigotes enhances infectivity for macrophage host cells.
    da Luz RI; Vermeersch M; Dujardin JC; Cos P; Maes L
    Antimicrob Agents Chemother; 2009 Dec; 53(12):5197-203. PubMed ID: 19752271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stage-specific activity of pentavalent antimony against Leishmania donovani axenic amastigotes.
    Ephros M; Bitnun A; Shaked P; Waldman E; Zilberstein D
    Antimicrob Agents Chemother; 1999 Feb; 43(2):278-82. PubMed ID: 9925518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimony susceptibility of Leishmania isolates collected over a 30-year period in Algeria.
    Eddaikra N; Ait-Oudhia K; Kherrachi I; Oury B; Moulti-Mati F; Benikhlef R; Harrat Z; Sereno D
    PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006310. PubMed ID: 29561842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimonial drugs entrapped into phosphatidylserine liposomes: physicochemical evaluation and antileishmanial activity.
    Borborema SE; Osso Junior JA; Andrade Junior HF; Nascimento Nd
    Rev Soc Bras Med Trop; 2016 Apr; 49(2):196-203. PubMed ID: 27192589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Canine visceral leishmaniasis: comparison of in vitro leishmanicidal activity of marbofloxacin, meglumine antimoniate and sodium stibogluconate.
    Vouldoukis I; Rougier S; Dugas B; Pino P; Mazier D; Woehrlé F
    Vet Parasitol; 2006 Jan; 135(2):137-46. PubMed ID: 16242844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene amplification in Leishmania tarentolae selected for resistance to sodium stibogluconate.
    Haimeur A; Ouellette M
    Antimicrob Agents Chemother; 1998 Jul; 42(7):1689-94. PubMed ID: 9661005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemistry of Pentostam resistant Leishmania.
    Berman JD; Edwards N; King M; Grogl M
    Am J Trop Med Hyg; 1989 Feb; 40(2):159-64. PubMed ID: 2537584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental visceral leishmaniasis: role of trans-aconitic acid in combined chemotherapy.
    Kar S; Kar K; Bhattacharya PK; Ghosh DK
    Antimicrob Agents Chemother; 1993 Nov; 37(11):2459-65. PubMed ID: 8285634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An in vitro model for screening antileishmanial drugs: the human leukaemia monocyte cell line, THP-1.
    Gebre-Hiwot A; Tadesse G; Croft SL; Frommel D
    Acta Trop; 1992 Aug; 51(3-4):237-45. PubMed ID: 1359751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimony resistance and trypanothione in experimentally selected and clinical strains of Leishmania panamensis.
    Goyeneche-Patino DA; Valderrama L; Walker J; Saravia NG
    Antimicrob Agents Chemother; 2008 Dec; 52(12):4503-6. PubMed ID: 18824610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of antileishmanial agents against amastigotes in human monocyte-derived macrophages and in mouse peritoneal macrophages.
    Berman JD; Lee LS
    J Parasitol; 1984 Apr; 70(2):220-5. PubMed ID: 6088749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of sodium stibogluconate and pentamidine on in vitro multiplication of Leishmania donovani in peritoneal macrophages from infected and drug-treated BALB/c mice.
    Sodhi S; Kaur S; Mahajan RC; Ganguly NK; Malla N
    Immunol Cell Biol; 1992 Feb; 70 ( Pt 1)():25-31. PubMed ID: 1322361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.